What is he best known for?
The fields of study he is best known for:
- Gene
- Internal medicine
- Neuron
His primary areas of investigation include Cannabinoid receptor, Cannabinoid, Neuroscience, Endocannabinoid system and Receptor.
The study incorporates disciplines such as Endocrinology and Pharmacology in addition to Cannabinoid receptor.
His Pharmacology research is multidisciplinary, incorporating perspectives in Cannabinoid Receptor Modulators, AM251, Agonist, Functional selectivity and Enzyme-linked receptor.
The Cannabinoid study combines topics in areas such as Neuroinflammation, Calcium channel, Anandamide, Angiotensin II and Vasodilation.
His Endocannabinoid system study integrates concerns from other disciplines, such as Nervous system, gamma-Aminobutyric acid, Metabotropic receptor, Depolarization-induced suppression of inhibition and Long-term depression.
His research investigates the link between Receptor and topics such as Cell biology that cross with problems in Biochemistry.
His most cited work include:
- International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors (2187 citations)
- Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system. (1330 citations)
- Identification and Functional Characterization of Brainstem Cannabinoid CB2 Receptors (1223 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Cannabinoid receptor, Endocannabinoid system, Cannabinoid, Neuroscience and Receptor.
His Cannabinoid receptor research integrates issues from Endocrinology, Pharmacology and Cell biology.
The Endocannabinoid system study combines topics in areas such as Cannabinoid receptor type 1, Signal transduction and Fatty acid amide hydrolase.
His biological study deals with issues like Hippocampus, which deal with fields such as Hippocampal formation.
His research in Neuroscience intersects with topics in Synaptic plasticity, Postsynaptic potential and Neurotransmission.
His primary area of study in Receptor is in the field of Internalization.
He most often published in these fields:
- Cannabinoid receptor (51.50%)
- Endocannabinoid system (44.50%)
- Cannabinoid (43.00%)
What were the highlights of his more recent work (between 2015-2021)?
- Endocannabinoid system (44.50%)
- Cannabinoid receptor (51.50%)
- Cannabinoid (43.00%)
In recent papers he was focusing on the following fields of study:
Ken Mackie focuses on Endocannabinoid system, Cannabinoid receptor, Cannabinoid, Receptor and Pharmacology.
He has researched Endocannabinoid system in several fields, including Anandamide, Endocrinology, Prefrontal cortex and Neuroscience.
The study incorporates disciplines such as Glutamate receptor and Synaptic plasticity in addition to Neuroscience.
His Cannabinoid receptor study incorporates themes from Cerebellum and Hippocampal formation.
His Cannabinoid research also works with subjects such as
- Cannabinoid receptor type 2 and related Allodynia,
- Inhibitory postsynaptic potential together with Glutamatergic.
He has included themes like Signal transduction and Cell biology in his Receptor study.
Between 2015 and 2021, his most popular works were:
- An Introduction to the Endogenous Cannabinoid System. (354 citations)
- Lipidomics profile of a NAPE-PLD KO mouse provides evidence of a broader role of this enzyme in lipid metabolism in the brain. (62 citations)
- Positive Allosteric Modulation of Cannabinoid Receptor Type 1 Suppresses Pathological Pain Without Producing Tolerance or Dependence (57 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Internal medicine
- Neuron
His primary areas of study are Cannabinoid receptor, Endocannabinoid system, Cannabinoid, Pharmacology and Internal medicine.
He is doing genetic studies as part of his Receptor and Biochemistry and Cannabinoid receptor investigations.
His Endocannabinoid system research includes themes of Glutamatergic, Prefrontal cortex, Anandamide and Hippocampus, Neuroscience.
The concepts of his Cannabinoid study are interwoven with issues in Rimonabant, Cannabinoid receptor type 2, Allosteric modulator, Pulmonary fibrosis and Cannabinoid receptor type 1.
His Pharmacology research is multidisciplinary, relying on both Agonist and Pathogenesis.
His Internal medicine study integrates concerns from other disciplines, such as Endocrinology, Orexin-A and Lipidomics.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
